Asenapine clinical trials
Also written Org 5222, Saphris and SCH 900274.
How each study uses asenapine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 13 Aug 2009 · SAPHRIS · NDA 022117 (FDA, Drugs@FDA)
- European Union
- 1 Sept 2010 · Sycrest · EMEA/H/C/001177 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
42 studies that test it; most in 2005 (13)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 13 |
| 2006 | 1 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 9 |
| 2013 | 3 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 34 · Other 8
Organon and Co (29) · Forest Laboratories (3) · Duke University (2) · Sun Pharmaceutical Industries Limited (1) · Noven Pharmaceuticals, Inc. (1) · Lori Davis, MD (1) · Unity Health Toronto (1) · University Hospitals Cleveland Medical Center (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Antipsychotics source
Studies
Open first, then newest update. How each study uses asenapine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 42
- 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)CompletedPhase 3Organon and CoNCT00143182Written as AsenapineHow we know
- An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)CompletedPhase 2Organon and CoNCT00878462Written as Asenapine WHITE raspberry flavor (Treatment A)How we know
- 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)CompletedPhase 3Organon and CoNCT00159744Written as AsenapineHow we know
- Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)CompletedPhase 3Organon and CoNCT00156104Written as AsenapineHow we know
- Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)CompletedPhase 3Organon and CoNCT00151424Written as asenapineHow we know
- Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)CompletedPhase 3Organon and CoNCT00156117Written as asenapineHow we know
- 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)CompletedPhase 3Organon and CoNCT00159796Written as AsenapineHow we know
- Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)CompletedPhase 3Organon and CoNCT00212836Written as asenapineHow we know
- Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)CompletedPhase 3Organon and CoNCT00212784Written as asenapineHow we know
- 6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)CompletedPhase 3Organon and CoNCT01098110Written as Asenapine 5 mgHow we know
- Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)CompletedPhase 3Organon and CoNCT01244815Written as asenapineHow we know
- A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)CompletedPhase 3Organon and CoNCT01617187Written as AsenapineHow we know
- Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)CompletedPhase 3Organon and CoNCT00764478Written as AsenapineHow we know
- Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125)CompletedPhase 3Organon and CoNCT01142596Written as AsenapineHow we know
- Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238)CompletedPhase 3Organon and CoNCT01244828Written as AsenapineHow we know
- A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1)CompletedPhase 1Organon and CoNCT01206517Written as Asenapine 2.5 mgHow we know
- Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)CompletedPhase 3Organon and CoNCT01190267Written as asenapineHow we know
- Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)CompletedPhase 3Organon and CoNCT01349907Written as AsenapineHow we know
- 12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)CompletedPhase 3Organon and CoNCT00145470Written as AsenapineHow we know
- Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)CompletedPhase 3Organon and CoNCT01190254Written as asenapine 2.5 mgHow we know
Codes
What other systems call asenapine · ClinicalTrials.gg INT005152
- MeSH (NLM) C522667asenapineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) JKZ19V908OASENAPINEConfirmed FDA, NLM, Wikidata
- RxNorm 784649One source FDA
- Wikidata Q27074536(S,S)-asenapineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C72705AsenapineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C522667 | asenapine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | JKZ19V908O | ASENAPINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 784649 | — | One source FDA |
| Wikidata | Q27074536 | (S,S)-asenapine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C72705 | Asenapine | One source FDA |
Also registered as asenapine maleate (UNII CU9463U2E2 · RxNorm 860647).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.